Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia. 1986

J C Pecknold, and R P Swinson

UI MeSH Term Description Entries
D008297 Male Males
D010200 Panic A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function. Panics
D010698 Phobic Disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable. Claustrophobia,Neuroses, Phobic,Phobia, School,Phobias,Phobic Neuroses,Scolionophobia,Disorder, Phobic,Phobia,Phobic Disorder,School Phobia
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000379 Agoraphobia Obsessive, persistent, intense fear of places or situations from which escape might be difficult or embarrassing. Phobia, Crowds,Phobia, Open Spaces,Crowds Phobia,Open Spaces Phobia
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889

Related Publications

J C Pecknold, and R P Swinson
October 1984, Texas medicine,
J C Pecknold, and R P Swinson
January 1996, Journal of psychopharmacology (Oxford, England),
J C Pecknold, and R P Swinson
February 1987, The American journal of psychiatry,
J C Pecknold, and R P Swinson
May 1994, The British journal of psychiatry : the journal of mental science,
J C Pecknold, and R P Swinson
February 1989, Journal of clinical psychopharmacology,
J C Pecknold, and R P Swinson
November 1992, The American journal of psychiatry,
J C Pecknold, and R P Swinson
July 1994, The British journal of psychiatry : the journal of mental science,
J C Pecknold, and R P Swinson
January 1997, Psychotherapy and psychosomatics,
J C Pecknold, and R P Swinson
March 1985, The Psychiatric clinics of North America,
Copied contents to your clipboard!